2020SVU-International Journal of Medical SciencesOpen access

Detection of Phospholipase A2 Receptor Related Membranous Nephropathy in Membranous Nephropathy Patient

Alaa Elmaghraby, Wesam Ismail, Amira A. Abdelnaby, Ali Taha Ali, Eman Muhammed Salah-Eldeen

Open full text 0 citations

Abstract

Background: Membranous glomerulonephritis (MGN) considered as the most common causes ofnephrotic syndrome (NS) in the world. Eighty percent of cases are classified as primary MGN. PrimaryMGN is an autoimmune disease in which autoantibodies against podocyte antigens forming subepithelialimmune deposits and result in NS. Autoantibodies against M-type phospholipase A2 receptor (PLA2R)were found in 70-80% of patients with primary MGN but not in those with secondary MGN or other renaldiseases. So, we aim to identify PLA2R associated primary MGN.Patient and methods: Out of 5000 native biopsies received from 2014-17, 600 were diagnosed as MGN,out of which 62 were stained for anti-PLA2R by immunoperoxidase. Nine cases of Lupus (SLE) Class V,12 of hepatitis C&B Virus MGN (10 HCV+ve and 2 HBV+ve) were used as controls. Positive wasdetermined as diffuse glomerular capillary wall staining.Results: Anti-PLA2R was positive in 61%(38/62) of cases (33 idiopathic cases and 5 cases of the control group3:HCV, 1 HBV, 1 SLE). None of theclinical parameters showed significance difference but nephrotic range proteinuria in the anti-PLA2R +vegroup was more (66% vs 46%). Histologically, onlymesangial matrix expansion was significantlydifferent in the aPLA2R –ve group (33% vs 10%, p=0.04).Conclusion: anti-PLA2R tissue staining is a reliable and specific method to identify primary MGN andshould be done routinely in all MGN cases even those identified as secondary on clinical basis.

Open-access reader

About this research paper

What this paper is about

Background: Membranous glomerulonephritis (MGN) considered as the most common causes ofnephrotic syndrome (NS) in the world. Eighty percent of cases are classified as primary MGN. PrimaryMGN is an autoimmune disease in which autoantibodies against podocyte antigens forming subepithelialimmune deposits and result in NS. Autoantibodies against M-type phospholipase A2 receptor (PLA2R)were found in 70-80% of patients with primary MGN but not in those with secondary MGN or other renaldiseases. So, we aim to identify PLA2R associated primary MGN.Patient and methods: Out of 5000 native biopsies received from 2014-17, 600 were diagnosed as MGN,out of which 62 were stained for anti-PLA2R by immunoperoxidase. Nine cases of Lupus (SLE) Class V,12 of hepatitis C&B Virus MGN (10 HCV+ve and 2 HBV+ve) were used as controls. Positive wasdetermined as diffuse glomerular capillary wall staining.Results: Anti-PLA2R was positive in 61%(38/62) of cases (33 idiopathic cases and 5 cases of the control group3:HCV, 1 HBV, 1 SLE). None of theclinical parameters showed significance difference but nephrotic range proteinuria in the anti-PLA2R +vegroup was more (66% vs 46%). Histologically, onlymesangial matrix expansion was significantlydifferent in the aPLA2R –ve group (33% vs 10%, p=0.04).Conclusion: anti-PLA2R tissue staining is a reliable and specific method to identify primary MGN andshould be done routinely in all MGN cases even those identified as secondary on clinical basis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background: Membranous glomerulonephritis (MGN) considered as the most common causes ofnephrotic syndrome (NS) in the world. Eighty percent of cases are classified as primary MGN. PrimaryMGN is an autoimmune disease in which autoantibodies against podocyte antigens forming subepithelialimmune deposits and result in NS. Autoantibodies against M-type phospholipase A2 receptor (PLA2R)were found in 70-80% of patients with primary MGN but not in those with secondary MGN or other renaldiseases. So, we aim to identify PLA2R associated primary MGN.Patient and methods: Out of 5000 native biopsies received from 2014-17, 600 were diagnosed as MGN,out of which 62 were stained for anti-PLA2R by immunoperoxidase. Nine cases of Lupus (SLE) Class V,12 of hepatitis C&B Virus MGN (10 HCV+ve and 2 HBV+ve) were used as controls. Positive wasdetermined as diffuse glomerular capillary wall staining.Results: Anti-PLA2R was positive in 61%(38/62) of cases (33 idiopathic cases and 5 cases of the control group3:HCV, 1 HBV, 1 SLE). None of theclinical parameters showed significance difference but nephrotic range proteinuria in the anti-PLA2R +vegroup was more (66% vs 46%). Histologically, onlymesangial matrix expansion was significantlydifferent in the aPLA2R –ve group (33% vs 10%, p=0.04).Conclusion: anti-PLA2R tissue staining is a reliable and specific method to identify primary MGN andshould be done routinely in all MGN cases even those identified as secondary on clinical basis.

Key concepts: Membranous nephropathy, Medicine, Receptor, Glomerulonephritis, Pathology, Internal medicine, Kidney

Related papers

Back to paper searchBrowse research topicsOriginal source
Detection of Phospholipase A2 Receptor Related Membranous Nephropathy in Membranous Nephropathy Patient — Research Paper | ScholarLens